Cross-source evidence timeline

Efpeglenatide research timeline

Follow 7 selected, directly cited source records from February 7, 2014 through July 7, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

7Selected records
4Source years
2Evidence lanes
July 7, 2026Latest source date

Source year

2026

2 records
  1. Clinical trials

    ClinicalTrials.gov record NCT06174779↗

    PeptideScanner retained ClinicalTrials.gov record NCT06174779 at 2026-11-16T17:34:46.889Z. Its registry update date was 2026-07-07, and PeptideScanner's reviewed identity mapping was efpeglenatide.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT07379333↗

    PeptideScanner retained ClinicalTrials.gov record NCT07379333 at 2026-11-16T17:34:46.889Z. Its registry update date was 2026-05-13, and PeptideScanner's reviewed identity mapping was efpeglenatide.↗

Source year

2025

1 record
  1. Literature metadata

    Population pharmacokinetics of efpeglenatide in individuals with obesity and with type 2 diabetes.↗

    PubMed lists PMID 41403449 in Frontiers in pharmacology as Journal Article, with publication-date metadata of 2025-12-01 (day precision). PeptideScanner associated the retained record with the identity slug efpeglenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2016

3 records
  1. Clinical trials

    ClinicalTrials.gov record NCT01452451↗

    PeptideScanner retained ClinicalTrials.gov record NCT01452451 at 2026-11-16T17:34:46.889Z. Its registry update date was 2016-08-09, and PeptideScanner's reviewed identity mapping was efpeglenatide.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT02075281↗

    PeptideScanner retained ClinicalTrials.gov record NCT02075281 at 2026-11-16T17:34:46.889Z. Its registry update date was 2016-08-09, and PeptideScanner's reviewed identity mapping was efpeglenatide.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT02081118↗

    PeptideScanner retained ClinicalTrials.gov record NCT02081118 at 2026-11-16T17:34:46.889Z. Its registry update date was 2016-08-09, and PeptideScanner's reviewed identity mapping was efpeglenatide.↗

Source year

2014

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT01093729↗

    PeptideScanner retained ClinicalTrials.gov record NCT01093729 at 2026-11-16T17:34:46.889Z. Its registry update date was 2014-02-07, and PeptideScanner's reviewed identity mapping was efpeglenatide.↗